IRIS Accounts Production v25.1.0.734 13864072 director 1.2.24 31.1.25 31.1.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary C 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138640722024-01-31138640722025-01-31138640722024-02-012025-01-31138640722023-01-31138640722023-02-012024-01-31138640722024-01-3113864072ns15:EnglandWales2024-02-012025-01-3113864072ns14:PoundSterling2024-02-012025-01-3113864072ns10:Director12024-02-012025-01-3113864072ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3113864072ns10:SmallEntities2024-02-012025-01-3113864072ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3113864072ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3113864072ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3113864072ns10:FullAccounts2024-02-012025-01-3113864072ns10:OrdinaryShareClass12024-02-012025-01-3113864072ns10:OrdinaryShareClass22024-02-012025-01-3113864072ns10:OrdinaryShareClass32024-02-012025-01-3113864072ns10:OrdinaryShareClass332024-02-012025-01-3113864072ns5:CurrentFinancialInstruments2025-01-3113864072ns5:CurrentFinancialInstruments2024-01-3113864072ns5:ShareCapital2025-01-3113864072ns5:ShareCapital2024-01-3113864072ns5:RetainedEarningsAccumulatedLosses2025-01-3113864072ns5:RetainedEarningsAccumulatedLosses2024-01-3113864072ns10:RegisteredOffice2024-02-012025-01-3113864072ns5:ComputerEquipment2024-02-012025-01-3113864072ns5:ComputerEquipment2024-01-3113864072ns5:ComputerEquipment2025-01-3113864072ns5:ComputerEquipment2024-01-3113864072ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3113864072ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3113864072ns5:DeferredTaxation2024-01-3113864072ns5:DeferredTaxation2024-02-012025-01-3113864072ns5:DeferredTaxation2025-01-3113864072ns10:OrdinaryShareClass12025-01-3113864072ns10:OrdinaryShareClass22025-01-3113864072ns10:OrdinaryShareClass32025-01-31138640721ns10:Director12024-01-31138640721ns10:Director12023-01-31138640721ns10:Director12024-02-012025-01-31138640721ns10:Director12023-02-012024-01-31138640721ns10:Director12025-01-31138640721ns10:Director12024-01-31
REGISTERED NUMBER: 13864072 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2025

for

Cedar Medicare Limited

Cedar Medicare Limited (Registered number: 13864072)






Contents of the Financial Statements
for the Year Ended 31 January 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


Cedar Medicare Limited (Registered number: 13864072)

Balance Sheet
31 January 2025

31.1.25 31.1.24
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 3,861 1,717

CURRENT ASSETS
Debtors 5 5,993 13,318
Cash at bank 113,704 81,331
119,697 94,649
CREDITORS
Amounts falling due within one year 6 11,203 13,150
NET CURRENT ASSETS 108,494 81,499
TOTAL ASSETS LESS CURRENT
LIABILITIES

112,355

83,216

PROVISIONS FOR LIABILITIES 7 734 326
NET ASSETS 111,621 82,890

CAPITAL AND RESERVES
Called up share capital 8 102 101
Retained earnings 111,519 82,789
SHAREHOLDERS' FUNDS 111,621 82,890

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 May 2025 and were signed by:




Dr Z Al-Rifai - Director


Cedar Medicare Limited (Registered number: 13864072)

Notes to the Financial Statements
for the Year Ended 31 January 2025

1. STATUTORY INFORMATION

Cedar Medicare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13864072

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 2 ) .

Cedar Medicare Limited (Registered number: 13864072)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2025

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 February 2024 2,696
Additions 3,055
At 31 January 2025 5,751
DEPRECIATION
At 1 February 2024 979
Charge for year 911
At 31 January 2025 1,890
NET BOOK VALUE
At 31 January 2025 3,861
At 31 January 2024 1,717

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.25 31.1.24
£    £   
Trade debtors 5,993 5,870
Directors' current accounts - 7,448
5,993 13,318

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.25 31.1.24
£    £   
Tax 9,848 12,370
Directors' current accounts 515 -
Accrued expenses 840 780
11,203 13,150

7. PROVISIONS FOR LIABILITIES
31.1.25 31.1.24
£    £   
Deferred tax 734 326

Deferred
tax
£   
Balance at 1 February 2024 326
Provided during year 408
Balance at 31 January 2025 734

Cedar Medicare Limited (Registered number: 13864072)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2025

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.25 31.1.24
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
1 Ordinary C £1 1 -
(31.1.24 - NIL)
102 101

Allotted and issued:
Number: Class: Nominal 31.1.25 31.1.24
value: £    £   
1 Share capital 3 £1 1 -
(31.1.24 - NIL)

The following shares were issued during the year for cash at par :

1 Ordinary C share of £1

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2025 and 31 January 2024:

31.1.25 31.1.24
£    £   
Dr Z Al-Rifai
Balance outstanding at start of year 7,448 (1,983 )
Amounts advanced 16,453 15,584
Amounts repaid (24,416 ) (6,153 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (515 ) 7,448

10. ULTIMATE CONTROLLING PARTY

The controlling party is Dr Z Al-Rifai.